<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta content="MSHTML 6.00.6001.18639" name="GENERATOR">
<!--[if !mso]>
<STYLE>v\:* {
BEHAVIOR: url(#default#VML)
}
o\:* {
BEHAVIOR: url(#default#VML)
}
w\:* {
BEHAVIOR: url(#default#VML)
}
.shape {
BEHAVIOR: url(#default#VML)
}
</STYLE>
<![endif]-->
<style><!--
/* Font Definitions */
@font-face
{font-family:SimSun;
panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
{font-family:SimSun;
panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
{font-family:"Arial Unicode MS";
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Consolas;
panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
{font-family:"\@SimSun";
panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
{font-family:"\@Arial Unicode MS";
panose-1:2 11 6 4 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:windowtext;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin-top:0in;
margin-right:-88.7pt;
margin-bottom:0in;
margin-left:0in;
margin-bottom:.0001pt;
text-indent:-81.0pt;
page-break-after:avoid;
font-size:14.0pt;
font-family:"Times New Roman","serif";
color:windowtext;
font-weight:bold;}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
margin:0in;
margin-bottom:.0001pt;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:windowtext;
font-weight:bold;}
h3
{mso-style-priority:9;
mso-style-link:"Heading 3 Char";
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:-.25in;
margin-bottom:.0001pt;
text-align:center;
page-break-after:avoid;
font-size:14.0pt;
font-family:"Times New Roman","serif";
color:windowtext;
font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
{mso-style-priority:35;
margin-top:0in;
margin-right:-88.7pt;
margin-bottom:0in;
margin-left:0in;
margin-bottom:.0001pt;
text-align:center;
text-indent:-81.0pt;
font-size:14.0pt;
font-family:"Times New Roman","serif";
color:windowtext;
font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-priority:99;
mso-style-link:"Body Text Char";
margin:0in;
margin-bottom:.0001pt;
text-align:center;
font-size:16.0pt;
font-family:"Times New Roman","serif";
color:windowtext;
font-weight:bold;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
{mso-style-priority:99;
mso-style-link:"Body Text Indent Char";
margin-top:0in;
margin-right:-88.7pt;
margin-bottom:0in;
margin-left:0in;
margin-bottom:.0001pt;
text-indent:-81.0pt;
font-size:10.0pt;
font-family:"Times New Roman","serif";
color:windowtext;}
p.MsoDate, li.MsoDate, div.MsoDate
{mso-style-priority:99;
mso-style-link:"Date Char";
margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:windowtext;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
{mso-style-priority:99;
mso-style-link:"Body Text Indent 2 Char";
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:-.25in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:windowtext;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Courier New";
color:windowtext;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
{mso-style-priority:99;
mso-style-link:"E-mail Signature Char";
margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:windowtext;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Arial Unicode MS","sans-serif";
color:black;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";
color:windowtext;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Cambria","serif";
color:#365F91;
font-weight:bold;}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.Heading3Char
{mso-style-name:"Heading 3 Char";
mso-style-priority:9;
mso-style-link:"Heading 3";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-priority:99;
mso-style-link:"Body Text";
font-family:"Calibri","sans-serif";}
span.BodyTextIndentChar
{mso-style-name:"Body Text Indent Char";
mso-style-priority:99;
mso-style-link:"Body Text Indent";
font-family:"Calibri","sans-serif";}
span.DateChar
{mso-style-name:"Date Char";
mso-style-priority:99;
mso-style-link:Date;
font-family:"Calibri","sans-serif";}
span.BodyTextIndent2Char
{mso-style-name:"Body Text Indent 2 Char";
mso-style-priority:99;
mso-style-link:"Body Text Indent 2";
font-family:"Calibri","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:Consolas;}
span.E-mailSignatureChar
{mso-style-name:"E-mail Signature Char";
mso-style-priority:99;
mso-style-link:"E-mail Signature";
font-family:"Calibri","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle36
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:black;}
span.EmailStyle37
{mso-style-type:personal;
font-family:"Arial","sans-serif";
font-variant:normal !important;
color:windowtext;
text-transform:none;
font-weight:normal;
font-style:normal;
vertical-align:baseline;}
span.EmailStyle38
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.EmailStyle39
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:#FF99CC;}
span.EmailStyle40
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:navy;}
span.style1
{mso-style-name:style1;}
span.b
{mso-style-name:b;}
span.EmailStyle43
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;
font-weight:normal;
font-style:normal;}
span.apple-style-span
{mso-style-name:apple-style-span;}
span.EmailStyle45
{mso-style-type:personal-reply;
font-family:"Verdana","sans-serif";
color:windowtext;
font-weight:normal;
font-style:normal;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body text="#000000" vlink="purple" bgcolor="white" lang="EN-US"
link="blue">
<small><font color="#0066cc"><font face="Arial">Forwarded
information (from Alex Pauling <a class="moz-txt-link-abbreviated" href="mailto:Alex@nobel-pauling.org">Alex@nobel-pauling.org</a>)</font></font></small>
for MIT Postdocs:<br>
<div>
<div>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><o:p><font face="Arial"><font
color="#008000"> </font></font></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"><font
color="#ff0000">IQPC’s Cancer Immunotherapy Conference |
February 27-29, 2012<o:p></o:p></font></font></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"><font
color="#ff0000">Location: Metro Meeting Centers, 101
Federal St, Boston</font></font></span></p>
<span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"><font
color="#ff0000">
</font></font>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"><font
color="#ff0000"><a
href="http://www.cancerimmunotherapyevent.com/Event.aspx?id=623580"><span
style="color: windowtext;">http://www.cancerimmunotherapyevent.com/Event.aspx?id=623580</span></a>
<o:p></o:p></font></font></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"><font
color="#ff0000"> </font></font></span></p>
</span><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"> <o:p></o:p></font></span>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial">Dr Grace Wong
(CEO of ActoKine Therapeutics) is a speaker for this
cancer immunotherapy conference on Feb 27-29, 2012 in
Boston, she can get <font color="#ff0000">10 free guest
passes</font> for MIT student, postdoc & scientists
(i.e., save </font></span><span style="font-size: 10pt;
font-family: 'Verdana','sans-serif';"><font face="Arial">$
2500)</font></span><span style="font-size: 10pt;
font-family: 'Verdana','sans-serif';"><font face="Arial">. </font></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"></span><font face="Arial"> </font></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><span style=""><font face="Arial">Register for
a free pass at <a href="http://www.nobel-pauling.org"><span
style="color: windowtext;">www.nobel-pauling.org</span></a>. </font></span><o:p></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><o:p><font face="Arial"> </font></o:p></span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; line-height:
normal;"><span style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial">Confirmed
Speakers Include: <o:p></o:p></font></span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; text-indent:
-0.25in; line-height: normal;"><span style="font-size: 10pt;
font-family: 'Verdana','sans-serif';"><font face="Arial">·</font></span><span
style="font-size: 10pt; font-family:
'Verdana','sans-serif';"><font face="Arial"> <span style="">
</span></font></span><span style="font-size: 10pt;
font-family: 'Verdana','sans-serif';"><font face="Arial">Grace
Wong, PhD, CEO, Actokine Therapeutics<br>
John Rothman, PhD, Executive VP: Science and Operations,
Advaxis Inc.<br>
Ramana Davuluri, PhD, Molecular and Cellular Oncogenesis
Program, Wistar Institute<br>
Elma Hawkins, PhD, Head of Clinical Development,
ImmunoCellular Therapeutics <br>
Jeffrey Schlom, PhD, Chief, Laboratory of Tumor Immunology
and Biology, NCI<br>
James Gulley, MD, PhD, Director, Laboratory of Tumor
Immunology and Biology, NCI<br>
Dirk Brockstedt, PhD, SVP, Research & Development,
Aduro BioTech<br>
Anthony Madia, PhD, MA, MBA, COO, Northwest
Biotherapeutics, Inc.<br>
Eric von Hofe, PhD, President, Antigen Express<br>
Ken Brasel, Scientist II, Dendreon Corporation <br>
Leisha Emens, MD, PhD, Professor, Oncology, Johns Hopkins
University of Medicine<br>
David Avigan, MD, Hematology-Oncology, Beth Israel
Deaconess Medical Center<br>
Nicola La Monica, PhD, Vice President, Idera
Pharmaceuticals<br>
John Vasilakos, PhD, Sr. Research Immunologist &
Business Director, 3M Company<br>
Mohamed Hussein, MD, Vice President, Medical Affairs,
Celgene<br>
Zihai Li, MD, PhD, Professor, Microbiology &
Immunology, University of South Carolina <o:p></o:p></font></span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt; text-indent:
-0.25in; line-height: normal;"><span style="font-size: 12pt;
color: black; font-family: 'Arial Unicode MS','sans-serif';"><o:p></o:p></span></p>
<o:p></o:p></div>
</div>
<div class="WordSection1">
<div>
<div>
<p class="MsoNormal" style="margin-right: 0.25in;"> <o:p></o:p></p>
<p class="MsoNormal" style="margin-right: 0.25in;"> <span
style="font-size: 11pt; font-family:
'Calibri','sans-serif';"><o:p></o:p></span></p>
</div>
<p class="MsoNormal"><!--[if gte vml 1]><v:shapetype id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
<v:stroke joinstyle="miter" />
<v:path gradientshapeok="t" o:connecttype="rect" />
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='position:absolute;margin-left:-9pt;margin-top:8.4pt;width:495pt;height:36pt;z-index:251657728' strokecolor="white" /><![endif]--><!--[if !vml]--><!--[endif]--><o:p> </o:p></p>
</div>
</div>
<hr noshade="noshade" size="1">
<p class="" avgcert="" color="#000000" align="left"><br>
</p>
</body>
</html>